Co-Delivery of Doxorubicin and Anti-BCL-2 siRNA by pH-Responsive Polymeric Vector to Overcome Drug Resistance in In Vitro and In Vivo HepG2 Hepatoma Model-Reference-Cited by-同舟云学术

Co-Delivery of Doxorubicin and Anti-BCL-2 siRNA by pH-Responsive Polymeric Vector to Overcome Drug Resistance in In Vitro and In Vivo HepG2 Hepatoma Model

Published:2018-04-24 Issue:6 Volume:19 Page:2248-2256
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Sun Weitong¹²³,Chen Xiaoyan¹,Xie Chao¹,Wang Yong¹^ORCID,Lin Liteng⁴,Zhu Kangshun⁴,Shuai Xintao¹^ORCID

Affiliation:

1. PCFM Lab of Ministry of Education, School of Materials Science and Engineering, Sun Yat-Sen University, Guangzhou, 510275, China

2. Department of Biomedical Engineering, School of Engineering, Sun Yat-sen University, Guangzhou, 510006, China

3. Pharmaceutical College of Jiamusi University, Jiamusi, 154007, China

4. Department of Minimally Invasive Interventional Radiology, and Department of Radiology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, China

Funder

Guangdong Innovative and Entrepreneurial Research Team Program

the Fundamental Research Funds for the Central Universities

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.8b00272

Reference40 articles.

1. Different strategies to overcome multidrug resistance in cancer

2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy